Equities

PhenixFIN Corp

PhenixFIN Corp

Actions
FinancialsClosed End Investments
  • Price (USD)47.02
  • Today's Change-0.580 / -1.22%
  • Shares traded822.00
  • 1 Year change+27.08%
  • Beta1.0216
Data delayed at least 15 minutes, as of Nov 12 2024 19:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform0
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Phenixfin Corp share price to fall to 35.00 in the next year from the last price of 47.02.
High-25.6%35.00
Med-25.6%35.00
Low-25.6%35.00

Dividends in USD

Historical dividend information is not available for PhenixFIN Corp.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Aug 06, 2024, Phenixfin Corp reported 3rd quarter 2024 earnings of 1.29 per share. This result exceeded the 0.65 expectation of the one analyst covering the company and under-performed last year's 3rd quarter results by 69.72%.
The next earnings announcement is expected on Dec 20, 2024.
Average growth rate-21.59%
Phenixfin Corp reported annual 2023 earnings of 12.87 per share on Dec 22, 2023.
Average growth rate+86.84%
More ▼

Revenue history & estimates in USD

Medley Capital Corporation had 3rd quarter 2024 revenues of 6.24m. This bettered the 5.17m estimate of the one analyst covering the company. This was 32.57% above the prior year's 3rd quarter results.
Average growth rate+8.35%
Medley Capital Corporation had revenues for the full year 2023 of 20.13m. This was 29.52% above the prior year's results.
Average growth rate-6.44%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.